These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6683262)

  • 41. Nicotine potentiation of morphine-induced catalepsy in mice.
    Zarrindast MR; Samadi P; Haeri-Rohani A; Moazami N; Shafizadeh M
    Pharmacol Biochem Behav; 2002 May; 72(1-2):197-202. PubMed ID: 11900788
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist.
    Tzschentke TM; Schmidt WJ
    Eur J Pharmacol; 1996 Jan; 295(2-3):137-46. PubMed ID: 8720577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unilateral injection of morphine into the nucleus accumbens induces akinesia and catalepsy, but no spontaneous muscular rigidity in rats.
    Winkler M; Havemann U; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):143-7. PubMed ID: 7199627
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of isomers of ketamine on catalepsy in the rat and electrical activity of the brain and behavior in the cat.
    Benthuysen JL; Hance AJ; Quam DD; Winters WD
    Neuropharmacology; 1989 Oct; 28(10):1003-9. PubMed ID: 2812279
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prolactin response to morphine in intact and adrenalectomized lactating rats.
    Kiem DT; Fekete MI; Bartha L; Nagy G; Makara GB
    Brain Res; 1991 Nov; 563(1-2):171-4. PubMed ID: 1786530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reversal of morphine-induced catalepsy in the rat by narcotic antagonists and their quaternary derivatives.
    Brown DR; Robertson MJ; Goldberg LI
    Neuropharmacology; 1983 Mar; 22(3):317-21. PubMed ID: 6682490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potentiation of catalepsy induced by narcotic agents during Haffner's test for analgesia.
    Beecham IJ; Handley SL
    Psychopharmacologia; 1974; 40(2):157-64. PubMed ID: 4476084
    [No Abstract]   [Full Text] [Related]  

  • 48. Potentiation of haloperidol-induced catalepsy by ascorbic acid in rats and nonhuman primates.
    Dorris RL; Dill RE
    Pharmacol Biochem Behav; 1986 Mar; 24(3):781-3. PubMed ID: 3703914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Theophylline reverses haloperidol-induced catalepsy in the rat. Possible relevance to the pharmacological treatment of psychosis.
    Casas M; Ferre S; Guix T; Jane F
    Biol Psychiatry; 1988 Oct; 24(6):642-8. PubMed ID: 3167148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacodynamic interactions of omeprazole with CNS active drugs in rats.
    Chandrashekhar SM; Chakrabarti A; Garg SK
    Indian J Physiol Pharmacol; 1995 Jan; 39(1):74-6. PubMed ID: 7705876
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
    Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Streptozotocin-induced diabetes differentially modifies haloperidol- and gamma-hydroxybutyric acid (GHB)-induced catalepsy.
    Sevak RJ; Koek W; France CP
    Eur J Pharmacol; 2005 Jul; 517(1-2):64-7. PubMed ID: 15975572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parametric influences on catalepsy.
    Sanberg PR; Pevsner J; Coyle JT
    Psychopharmacology (Berl); 1984; 82(4):406-8. PubMed ID: 6427835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ontogenesis of morphine-induced behavior in the rat.
    Caza PA; Spear LP
    Pharmacol Biochem Behav; 1980 Jul; 13(1):45-50. PubMed ID: 7190709
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Catalepsy after microinjection of haloperidol into the rat medial prefrontal cortex.
    Klockgether T; Schwarz M; Turski L; Sontag KH
    Exp Brain Res; 1988; 70(2):445-7. PubMed ID: 3384045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [High dosage haloperidol reduces cataleptic response with increased noradrenaline metabolism in the rat brain areas].
    Takashima M; Toru M
    Yakubutsu Seishin Kodo; 1983 Dec; 3(3):149-58. PubMed ID: 6687201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy.
    Moo-Puc RE; Góngora-Alfaro JL; Alvarez-Cervera FJ; Pineda JC; Arankowsky-Sandoval G; Heredia-López F
    Neuropharmacology; 2003 Sep; 45(4):493-503. PubMed ID: 12907310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality.
    Trujillo KA; Akil H
    Pharmacol Biochem Behav; 1991 Mar; 38(3):673-5. PubMed ID: 1829839
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Haloperidol-induced catalepsy is influenced by calcium channel antagonists.
    Biała G
    Acta Pol Pharm; 2000; 57(3):233-7. PubMed ID: 11143713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estrogen and haloperidol-induced versus handling-related catalepsy in male rats.
    De Ryck M; Hruska RE; Silbergeld EK
    Pharmacol Biochem Behav; 1982 Nov; 17(5):1027-35. PubMed ID: 7178196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.